VCG
USNA icon

Vantage Consulting Group’s Usana Health Sciences USNA Stock Holding History

Vantage Consulting Group’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-377
Closed -$29K – 1513
2020
Q4 		$29K Buy
+377
New +$29.2K ﹤0.01% 706

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Vantage Consulting Group's USNA Position: Q1 2021 in Review

Vantage Consulting Group sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 377 shares — an estimated $29K sold.

Vantage Consulting Group first reported a position in USNA in Q4 2020 and held it in 1 quarter. The position peaked at $29K in Q4 2020. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

  • Vantage Consulting Group reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 377 Usana Health Sciences shares in Q1 2021, an estimated $29K.
  • Vantage Consulting Group first reported a position in Usana Health Sciences in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Usana Health Sciences position peaked at $29K in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.